Revelation Pharma

  1. February 11, 2023

    Revelation Pharma Completes Fifteenth Acquisition – Stanley Specialty Pharmacy

    Revelation Pharma Completes Fifteenth Acquisition – Purchases Stanley Specialty Pharmacy

    TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the fifteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Stanley Specialty Pharmacy located in Charlotte, North Carolina. Stanley Specialty Pharmacy is a PCAB accredited, 503A compounding pharmacy that is dedicated to enhancing the quality of patients’ lives through creative, individualized pharmaceutical treatments and incomparable customer care.

    The purchase of Stanley Specialty Pharmacy signifies Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life. 

    “As a compounding industry veteran, I have witnessed the numerous changes

    Read More
  2. February 08, 2023

    Revelation Pharma Completes Fourteenth Acquisition – Makers Compounding Pharmacy

    Revelation Pharma Completes Fourteenth Acquisition – Purchases Makers Compounding Pharmacy

    TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the fourteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Markers Compounding Pharmacy located in Mount Vernon, Washington. Makers Compounding Pharmacy is a PCAB accredited, 503A compounding pharmacy that offers compounded preparations to each individual patient and while working alongside their health care provider to specialize the delivery method to fit the patient’s lifestyle and special needs.

    The purchase of Makers Compounding Pharmacy signifies Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life.

    “I’m overjoyed

    Read More
  3. December 16, 2022

    Revelation Pharma Completes Thirteenth Acquisition – Purchases Clinical Community Pharmacy

    TAMPA, Fla., – Osceola Capital (“Osceola”), a lower middle-market private equity firm, announced today the thirteenth addition to the Revelation Pharma Corporation (“Revelation”) platform. Revelation purchased Community Clinical Pharmacy located in Mesa, Arizona. Community Clinical Pharmacy is a 503A compounding pharmacy with more than 42 years of expertise, offering patients and healthcare professionals the highest quality compounded preparations to help optimize health. 

    The purchase of Community Clinical Pharmacy highlights Revelation’s continuous objective to create a network of 503A and 503B compounding pharmacies across the country. Compounding pharmacies prepare high-quality, tailored prescriptions to meet a specific therapeutic need, often enhancing patients’ quality of life. 

    “We’re excited to join the Revelation family of pharmacies. Through Revelation’s vision and market-leading expertise, we look forward to Community Clinical Pharmacy’s ability to help our community

    Read More
  4. November 11, 2022

    Shawn E. Hodges, PharmD, named a 2021-2022 School of Pharmacy Distinguished Alumni

    Congratulations to #TTUHSCSOP alumnus Shawn E. Hodges, PharmD, on recently being named a 2021-2022 School of Pharmacy Distinguished Alumni. 

    The TTUHSC Alumni Association honored Dr. Hodge’s accomplishments and contributions by presenting him with the Pharmacy Leadership Award at a ceremony held on Oct. 21.

    Dr. Hodges graduated with a Doctorate in Pharmacy from TTUHSC School of Pharmacy in 2001. Upon graduation, Dr. Hodges was awarded a one-year fellowship with Eli Lilly where he served as a liaison between the FDA and the Lilly Regulatory Affairs team. After completing his fellowship, he developed telehealth training courses and lectures for hospice pharmacy practitioners focusing on the appropriate use of compound medications for patients receiving end of life care. 

    In 2007, Dr. Hodges purchased a compounding-only pharmacy called Innovation Compounding which focused on treatment for hospice patients, men’s health, women’s health, animal health, and wellness therapies.

    Read More
Page